22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA

Clinical trial NCT03903471 · UNKNOWN

Trial details

NCT number: NCT03903471
Sponsor: Jiayuan Sun
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymph Node Disease

Start date: 2022-10-08
Primary completion: 2023-10-08
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.